Percutaneous Coronary Intervention of Saphenous Vein Graft
Author(s) -
Björn Redfors,
Philippe Généreux,
Bernhard Witzenbichler,
Thomas McAndrew,
Jamie Diamond,
Xin Huang,
Akiko Maehara,
Giora Weisz,
Roxana Mehran,
Ajay J. Kirtane,
Gregg W. Stone
Publication year - 2017
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.117.004953
Subject(s) - medicine , percutaneous coronary intervention , saphenous vein graft , percutaneous , cardiology , vascular closure device , conventional pci , surgery , radiology , myocardial infarction , artery
Percutaneous coronary intervention (PCI) of saphenous vein grafts (SVGs) has historically been associated with a high risk of adverse ischemic events, but there is a paucity of contemporary data on the second-generation drug-eluting stent use within SVG, and the relative importance of high platelet reactivity (HPR) in SVG PCI versus native lesion PCI is unknown. We studied ischemic and bleeding events after SVG PCI and their association with HPR.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom